Until relatively recently, private equity buyers were viewed as largely benign. Where antitrust regulators expressed concerns with private equity buyers, it was generally in the context of them being viewed as sub-optimal divestiture buyers. This changed during the Trump administration where the Democratic minority began to voice concerns about the incentives of private equity players. The rhetoric has increased in intensity during the Biden administration which has brought challenges targeting
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.138.170.67
Please verify email or join us to access premium content!